Supplement Individual Article: United States Cutaneous Oncodermatology Management (USCOM) II: A Multidisciplinary-Guided Algorithm for the Prevention and Management of Acute Radiation Dermatitis in Cancer Patients

November 2022 | Volume 21 | Issue 11 | SF35856914 | Copyright © November 2022


Jonathan Leventhal MDa, Mario E. Lacouture MD FAADb, Anneke E. Andriessen PhDc, Beth N. McLellan MDd, Alice Ho MD MBAe

aDepartment of Dermatology, Smilow Cancer Hospital at Yale, New Haven, CT
bDivision of Oncodermatology, Memorial Sloan Kettering Cancer Center, New York, NY
cRadboud UMC, Nijmegen and Andriessen Consultants, Malden, The Netherlands
dDepartment of Medicine, Division of Dermatology, Albert Einstein College of Medicine, Bronx, NY
eDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA



tools for preventing and managing RD by providing uniform guidelines that lead to a reduction in cAEs.7 An algorithm was previously published to treat cAEs, reduce their incidence, and maintain healthy skin using general measures and over-thecounter agents (OTC; Figure 1).7 This algorithm aims to inform all healthcare providers treating oncology patients, including physicians, nurses, radiation therapists, pharmacists, and advanced providers.7 The next logical step was to develop a pragmatic, decision-based algorithm on skincare management to standardize clinical practices, RT-related acute RD severity, and ultimately improve patient comfort during RT.

Multifactorial etiologies of radiation dermatitis
On a biological level, RD is defined as a cutaneous inflammatory reaction induced by exposure to biologically effective levels of ionizing radiation.6-10,23-30 The mechanisms associated with